1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Disruptive Behavior: new trials by email Literature Review of Disruptive Behavior trials Research Report on Disruptive Behavior
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prazosin for Agitation in Alzheimer's Disease Prazosin, Placebo oral capsule - Alzheimer's Disease, Disruptive Behavior | Phase 2 | Completed | Alzheimer's Disease Cooperative Study (ADCS) | 35 | 2018-10-23 | 2023-02-06 |
Alzheimer Disease (1) · Dementia (1) · Problem Behavior (1) · Psychomotor Agitation (1)
Aberrant Motor Behavior in Dementia (1) · Behavior (1) · Behavioral Symptoms (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Child Behavior (1) · Dyskinesias (1) · Mental Disorders (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurocognitive Disorders (1) · Neurodegenerative Diseases (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Psychomotor Disorders (1)
Prazosin (1)
Alzheimer's Disease Cooperative Study (ADCS) (1)
United States (1)
Howard Feldman (1)
U19AG010483 (1)